Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Biobusiness Briefs
  • Published:

Trial watch

Impact of genetically supported target selection on R&D productivity

A Corrigendum to this article was published on 12 September 2016

This article has been updated

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Impact of genetically supported target selection on R&D productivity.

Change history

  • 12 September 2016

    and 17 October 2016 The values shown on the y axis of Figure 1b were incorrect. These have now been corrected in the online versions of the article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lon R. Cardon.

Ethics declarations

Competing interests

The authors are employees and shareholders of GlaxoSmithKline.

Supplementary information

Supplementary information S1 (box)

Data and analysis (PDF 272 kb)

Supplementary information S2 (table)

Supplementary information (XLSX 18 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hurle, M., Nelson, M., Agarwal, P. et al. Impact of genetically supported target selection on R&D productivity. Nat Rev Drug Discov 15, 596–597 (2016). https://doi.org/10.1038/nrd.2016.164

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2016.164

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research